Gounder MM et al. Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT). ESMO 2022;Abstract 1488MO.

Gounder MM et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med 2018;379(25):2417-28. Abstract

Kasper B et al. DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT). ESMO 2022;Abstract LBA2.

Toulmonde M et al. DESMOPAZ pazopanib (PZ) versus IV methotrexate/vinblastine (MV) in adult patients with progressive desmoid tumors (DT): A randomized phase II study from the French Sarcoma Group. ASCO 2018;Abstract 11501.